Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04558034 · ClinicalTrials.gov registry record · NA
The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
A NA study, sponsored by Parkview Health.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04558034 is a NA study that was terminated before completion, run by Parkview Health. The registered enrollment target is 14 participants.
The verdict
NCT04558034, a NA study, was terminated before completion, sponsored by Parkview Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will determine the efficacy of cryotherapy to prevent paclitaxel-induced peripheral neuropathy and nail changes in women with breast cancer.
Interventions
- OTHER cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-08-04 |
| Est. Completion | 2021-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04558034
The ClinicalTrials.gov registry entry for NCT04558034 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parkview Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cryotherapy is the first listed.
NCT04558034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04558034 about?
NCT04558034 is a clinical study titled "The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer". This study will determine the efficacy of cryotherapy to prevent paclitaxel-induced peripheral neuropathy and nail changes in women with breast cancer.
What is the current status of trial NCT04558034?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-08-04. Estimated completion is 2021-02-03.
What interventions are being tested in trial NCT04558034?
The interventions under investigation include: cryotherapy (OTHER).
Who is sponsoring clinical trial NCT04558034?
This trial is sponsored by Parkview Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.